ALLR
Allarity Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website allarity.com
- Employees(FY) -
- ISIN US0167444019
Performance
-15.25%
1W
-61.96%
1M
-92.07%
3M
-93.49%
6M
-94.2%
YTD
-99.77%
1Y
Profile
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company has a collaboration with Detsamma Investments Pty. Ltd. to develop Deflexifol for the treatment of solid tumors. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Technical Analysis of ALLR 2024-05-10
Overview:
In analyzing the technical indicators for ALLR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been consistently below the closing price, ind...
Recent News & Updates
- 2024-05-14 18:53
- 2024-05-14 04:01
- 2024-05-07 00:00
- 2024-05-06 21:30
- 2024-05-05 22:21
- 2024-05-05 20:00
- 2024-05-01 23:27
- 2024-05-01 23:13
- 2024-05-01 20:00
- 2024-04-28 19:00
- 2024-04-16 21:10
- 2024-04-11 20:18
Why Is Allarity Therapeutics (ALLR) Stock Up 41% Today?(Investorplace)
- 2024-04-03 21:15
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split(Globenewswire)
- 2024-03-26 20:30
- 2024-03-24 19:30
- 2024-03-07 18:15
- 2024-02-27 17:00
Allarity Therapeutics to Present at Biomarkers 2024(Globenewswire)
- 2023-12-11 17:00
- 2023-12-04 21:07
Why Is Allarity Therapeutics (ALLR) Stock Up 42% Today?(Investorplace)
- 2023-12-04 18:30
- 2023-10-01 19:00
Allarity Therapeutics to Present at Biomarkers Europe 2023(Globenewswire)
- 2023-09-13 21:25
- 2023-08-30 04:05
- 2023-07-30 18:00
- 2023-07-23 18:00
- 2023-07-11 16:00
ALLR: IXEMPRA Clinical Update(Yahoo Finance)
- 2023-07-05 18:00
- 2023-07-04 21:45
- 2023-06-27 23:55
- 2023-06-27 06:16
Page 1 of 3
previousnext